March 16, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Vistagen Therapeutics, Inc. (“Vistagen” or “the Company”) (NASDAQ: VTGN). Investors who purchased Vistagen securities prior to April 1, 2024, and continue to hold to the present, are encouraged to obtain additional… read more
March 16, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating the sale of National Storage Affiliates Trust (“National Storage”) (NYSE: NSA) to Public Storage for 0.14 of a share of Public Storage common stock or partnership units for each National Storage share or unit. Investors who purchased National… read more
March 16, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Horizon Technology Finance Corporation (“Horizon” or “the Company”) (NASDAQ: HRZN). Investors who purchased Horizon securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Horizon has… read more
March 16, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Marriott Vacations Worldwide Corporation (“Marriott Vacations” or “the Company”) (NYSE: VAC). Investors who purchased Marriott Vacations securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether… read more
March 13, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Zillow Group, Inc. (“SZillow” or “the Company”) (NASDAQ: ZG). Investors who purchased SZillow securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether SZillow has violated… read more
March 13, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Jefferies Financial Group, Inc. (“Jefferies” or “the Company”) (NYSE: JEF). Investors who purchased Jefferies securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Jefferies has… read more
March 12, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of BlackRock, Inc. (“BlackRock” or “the Company”) (NYSE: BLK). Investors who purchased BlackRock securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether BlackRock has violated federal… read more
March 12, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Snap, Inc. (“Snap” or “the Company”) (NYSE: SNAP). Investors who purchased Snap securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Snap has violated federal… read more
March 12, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of CVRx, Inc. (“CVRx” or “the Company”) (NASDAQ: CVRX). Investors who purchased CVRx securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether CVRx has violated federal… read more
March 12, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Encompass Health Corporation (“Encompass” or “the Company”) (NYSE: EHC). Investors who purchased Encompass securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Encompass has violated… read more
March 10, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Edison International (“Edison” or “the Company”) (NYSE: EIX). Investors who purchased Edison securities prior to February 25, 2021, and continue to hold to the present, are encouraged to obtain additional information… read more
March 10, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Varonis Systems, Inc. (“Varonis” or “the Company”) (NASDAQ: VRNS). Investors who purchased Varonis securities prior to February 4, 2025, and continue to hold to the present, are encouraged to obtain additional… read more
March 10, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Ardent Health, Inc. (“Ardent” or “the Company”) (NYSE: ARDT). Investors who purchased Ardent securities prior to July 18, 2024, and continue to hold to the present, are encouraged to obtain additional… read more
March 10, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sprouts Farmers Market, Inc. (“Sprouts” or “the Company”) (NASDAQ: SFM). Investors who purchased Sprouts securities prior to June 4, 2025, and continue to hold to the present, are encouraged to obtain… read more
March 10, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Centene Corporation (“Centene” or “the Company”) (NYSE: CNC). Investors who purchased Centene securities prior to December 12, 2024, and continue to hold to the present, are encouraged to obtain additional information… read more
March 10, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of iRhythm Technologies, Inc. (“iRhythm” or “the Company”) (NASDAQ: IRTC). Investors who purchased iRhythm securities prior to January 11, 2022, and continue to hold to the present, are encouraged to obtain additional… read more
March 10, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lockheed Martin Corporation (“Lockheed” or “the Company”) (NYSE: LMT). Investors who purchased Lockheed securities prior to January 23, 2024, and continue to hold to the present, are encouraged to obtain additional… read more
March 10, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of DexCom, Inc. (“DexCom” or “the Company”) (NASDAQ: DXCM). Investors who purchased DexCom securities prior to January 8, 2024, and continue to hold to the present, are encouraged to obtain additional information… read more
March 10, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Future FinTech Group Inc. (“Future FinTech” or “the Company”) (NASDAQ: FTFT). Investors who purchased Future FinTech securities prior to March 10, 2020, and continue to hold to the present, are encouraged… read more
March 9, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sempra (“Sempra” or “the Company”) (NYSE: SRE). Investors who purchased Sempra securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Sempra has violated federal securities… read more
March 6, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Hims & Hers Health, Inc. (“Hims & Hers” or “the Company”) (NYSE: HIMS). Investors who purchased Hims & Hers securities prior to April 1, 2025, and continue to hold to the… read more
March 4, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Barclays PLC (“Barclays” or “the Company”) (NYSE: BCS). Investors who purchased Barclays securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Barclays has violated federal… read more
March 4, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Banco Santander, S.A. (“Santander” or “the Company”) (NYSE: SAN). Investors who purchased Santander securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Santander has violated… read more
March 4, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of SLM Corporation a/k/a Sallie Mae (“SLM” or “the Company”) (NASDAQ: SLM). Investors who purchased SLM securities prior to July 25, 2025, and continue to hold to the present, are encouraged to… read more
March 4, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Elevance Health, Inc. (“Elevance” or “the Company”) (NYSE: ELV). Investors who purchased Elevance securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Elevance has violated… read more
March 4, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Elauwit Connection, Inc. (“Elauwit” or “the Company”) (NASDAQ: ELWT). Investors who purchased Elauwit securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Elauwit has violated… read more
March 2, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Duolingo, Inc. (“Duolingo” or “the Company”) (NASDAQ: DUOL). Investors who purchased Duolingo securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Duolingo has violated federal… read more
March 2, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Rambus Inc. (“Rambus” or “the Company”) (NASDAQ: RMBS). Investors who purchased Rambus securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Rambus has violated federal… read more
March 2, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Fluor Corporation (“Fluor” or “the Company”) (NYSE: FLR). Investors who purchased Fluor securities prior to February 18, 2025, and continue to hold to the present, are encouraged to obtain additional information… read more
February 27, 2026 |
Bronstein, Gewirtz & Grossman, LLC is investigating Mister Car Wash, Inc. (“Mister Car Wash”) (NASDAQ: MCW) for potential breaches of fiduciary duty on the part of its directors and management. Investors who purchased Mister Car Wash and continue to hold to the present are encouraged… read more